Trial
NCT03407976
Apatinib With Pembrolizumab in Previously Treated Advanced Malignancies
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Utah
Collaborators
Elevar Therapeutics
Condition
Advanced Malignancies
Intervention
Apatinib
Why stopped
Funding source withdrew financial support prior to start of Phase II portion of study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-15